dc.contributor.author |
Heider, Nele |
|
dc.contributor.author |
Schatz, Andreas |
|
dc.contributor.author |
Schnichels, Sven |
|
dc.contributor.author |
Januschowski, Kai |
|
dc.contributor.author |
Hurst, José |
|
dc.contributor.author |
Spitzer, Martin Stephan |
|
dc.date.accessioned |
2023-01-16T08:47:27Z |
|
dc.date.available |
2023-01-16T08:47:27Z |
|
dc.date.issued |
2022 |
|
dc.identifier.issn |
1663-9812 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/135373 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Frontiers Media Sa |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.3389/fphar.2022.817353 |
de_DE |
dc.subject.ddc |
610 |
de_DE |
dc.title |
Long-Term Biocompatibility of a Highly Viscously Thiol-Modified Cross-Linked Hyaluronate as a Novel Vitreous Body Substitute |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20220728000000_01704 |
|
utue.personen.roh |
Hurst, Jose |
|
utue.personen.roh |
Rickmann, Annekatrin |
|
utue.personen.roh |
Heider, Nele |
|
utue.personen.roh |
Hohenadl, Christine |
|
utue.personen.roh |
Reither, Charlotte |
|
utue.personen.roh |
Schatz, Andreas |
|
utue.personen.roh |
Schnichels, Sven |
|
utue.personen.roh |
Januschowski, Kai |
|
utue.personen.roh |
Spitzer, Martin S. |
|
dcterms.isPartOf.ZSTitelID |
Frontiers in Pharmacology |
de_DE |
dcterms.isPartOf.ZS-Issue |
Article 817353 |
de_DE |
dcterms.isPartOf.ZS-Volume |
13 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |